Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 2/20 | 0.37 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.35 |
| ▸ | NMT2 | O60551 | 1/20 | 0.34 |
| ▸ | NMT1 | P30419 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25128366 | 1.00 | GLP1R (0.45) | GLP1RTSHRBRD4NOD1FOLH1 | |
| SCHEMBL24581687 | 1.00 | GLP1R (0.45) | GLP1RTSHRBRD4NOD1FOLH1 | |
| SCHEMBL25128875 | 0.94 | GLP1R (0.48) | GLP1RTSHRNOD1FOLH1NMT2 | |
| SCHEMBL25128374 | 0.88 | GLP1R (0.43) | GLP1RTSHRBRD4NOD1FOLH1 | |
| SCHEMBL27312935 | 0.88 | GLP1R (0.43) | GLP1RTSHRBRD4NOD1FOLH1 | |
| SCHEMBL27312248 | 0.88 | GLP1R (0.43) | GLP1RTSHRBRD4NOD1FOLH1 | |
| SCHEMBL25129007 | 0.88 | GLP1R (0.43) | GLP1RTSHRBRD4NOD1FOLH1 | |
| SCHEMBL25128368 | 0.88 | GLP1R (0.43) | GLP1RTSHRBRD4NOD1FOLH1 | |
| SCHEMBL25128698 | 0.85 | TSHR (0.43) | GLP1RTSHRFOLH1HPGD | |
| SCHEMBL23729451 | 0.83 | TSHR (0.51) | GLP1RTSHRBRD4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023040793-A1 | ANTI-INFLAMMATORY COMPOUND AND USE THEREOF | 映恩生物制药（苏州）有限公司 | 2023-03-23 | — | — | WO | disclosed |